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The effectiveness of mindfulness-based intervention for 
people with schizophrenia: a systematic review
Angie Ho Yan Lam1, Wai Tong Chien2,†
SUMMARY
Background:
With its known benefits in other mental illnesses, there have been increasing interest 
to understand the effects of mindfulness-based intervention (MBI) in schizophrenia. 
The systematic review aimed to summarize and synthesize the evidence regarding the 
effectiveness of MBI for people with schizophrenia.
Methods: 
The review was conducted according to the Preferred Reporting Items for Systematic reviews 
and meta-Analyses (PRISMA) statement. Relevant studies systematically searched from seven 
main electronic databases. The studies included were assessed for their methodological 
qualities using the standard Cochrane’s risk of bias assessment tool. Estimated effect sizes of 
the main study outcomes were calculated to assess/estimate the magnitude of the treatment 
effects of MBI in schizophrenia.
Results: 
Six experimental studies were selected for inclusion in the analysis. The study results were not 
appropriate to be combined for meta-analysis due to marked variations in the study designs, 
interventions and reported outcome measures. The findings show that there are potential effects 
of MBI for patients with schizophrenia on emotional regulation, global functioning and prevention 
of relapse. However, there was insufficient evidence to indicate these promising effects.
Conclusion: 
While mindfulness-based intervention may result in several benefits in schizophrenia, 
there is insufficient evidence to demonstrate its promising effects and evidence-based 
recommendations. More research is warranted to identify the therapeutic components and 
treatment effects of MBI in diverse samples with schizophrenia spectrum disorders. 
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Introduction 
Schizophrenia is a severe mental illness often 
characterized by abnormal cognitive, volitional, 
perceptual, and behavioral manifestations such 
as persistent delusions, disorganized thinking, 
auditory hallucinations, social withdrawal, 
Neuropsychiatry (London)   (2016) 6(5)209
Review Wai Tong Chien
conditions, ranging from pain, stress, anxiety, 
severe and recurrent depression disorders, and 
eating disorders [7].
Schizophrenia is a chronic illness condition 
with persistent abnormal perception and 
cognition, particularly hallucinations and 
delusions. Despite psychopharmacological 
treatment, patients with schizophrenia continue 
to experience residual psychotic symptoms 
resulting in bizarre behaviors, significant distress, 
emotional disturbance, and gradual functional 
impairments [8]. Patients conventionally 
adopted experiential avoidance strategies such 
as distraction, avoidance and suppression; some 
even get lost in the struggle of rumination and 
confrontation of symptoms [9]. This avoidance 
approach exacerbates distress and anxiety, which 
are strongly associated with risk of relapse and 
re-hospitalization [10]. Mindfulness-based 
intervention (MBI) is believed to help patients 
with schizophrenia relate differently to their 
psychotic experiences by opening their awareness 
and non-judgmental acceptance and allow a 
more adaptive strategy of coping and control over 
those psychotic symptoms to be used by patients 
with schizophrenia [11,12]. A few qualitative 
research reported that MBI could promote a 
range of benefits for patients with psychotic 
disorders. The patients with schizophrenia in the 
studies reported that they reclaimed one’s power 
by letting the psychotic symptoms to come and 
go without exaggerated negative reactions. MBI 
may empower one’s ability to accept and tolerate 
various difficult/negative thoughts and feelings, 
and achieve a sense of greater calm and peace of 
mind [13]. Despite a few studies reported MBI 
could be potentially harmful by exacerbating 
patients’ psychotic symptoms, growing evidence 
have suggested the MBI can be effective to 
reinforce and empower patients’ self-regulation 
and management of the illness. To understand 
the effects of MBI for people with schizophrenia, 
this systematic review was to summarize and 
synthesize the current research evidence on the 
effectiveness and feasibility of MBI for people 
with schizophrenia. Hence, it can provide 
recommendations on the use of MBI for practice 
and further research. 
Methods
  Protocol and registration
The protocol was registered in PROSPERO 
International prospective register of systematic 
reviews (PROSPERO 2016:CRD42016039718); 
and this proposal is available at http://www.
lack of motivation, and apathy [1]. In 2013, 
there were about 24 million people with this 
disorder globally and its 12-month prevalence 
was 1.1-1.8% of adult populations [2]. 
Although antipsychotic medications can reduce 
the psychotic symptoms (mainly positive 
symptoms), many psychotic patients continue 
to experience disabling residual symptoms and 
impaired functioning, as well as high risk of 
relapses from the illness.
Recent systematic reviews on psycho-education 
and other psychosocial interventions in 
schizophrenia suggest that psycho-education 
and behavioural management programmes (in 
either individual or group basis) are consistently 
effective in reducing relapse and enhancing 
medication adherence [1,3,4]. Nevertheless, 
most of these psychosocial interventions only 
provide limited strategies in motivating and 
empowering self-management of the illness 
and pay little attention towards helping people 
develop an acceptance of the illness and the 
incomprehensible and stressful experiences 
of psychotic symptoms [1,4]. Therefore, the 
benefits of psychosocial interventions seem 
to be short to medium term with only slight 
improvements in psychosocial functioning, 
resulting in the general pattern of unsuccessful 
long-term coping or adjustments in the recurrent 
courses of schizophrenia.
  Mindfulness and schizophrenia
An evidence-based psychological therapy for 
a few mental illnesses such as depression and 
anxiety disorders named mindfulness-based 
intervention (MBI) has been increasingly 
attracted attention and interest in applying 
to the treatment of schizophrenia and other 
psychotic disorders. Mindfulness refers to the 
awareness of and focused attention to one’s 
own moment to moment experiences with 
a nonjudgmental and acceptance stance [5]. 
Mindfulness requires intentionally observes and 
explores one’s inner experience with calmness 
and non-reactivity. Through mindful training 
and exercises, an individual can learn to accept 
his/her thoughts and feelings and to let go 
his/her dysfunctional cognitive, emotional 
and behavioral manifestations [6]. Therefore, 
mindfulness training can improve one’s ability 
to regulate emotion and thought process in a 
more constructive manner and responses [6]. 
Previous studies have indicated that MBI can be 
effective in improving psychosocial functioning 
for healthy people and a variety of illness 
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  Search strategy 
The review identified the published peer-
reviewed journal articles and theses in English 
language. Systematic searching was made on 
six electronic databases: COCHRANE library, 
MEDLINE (1961-2016), CINAHL (1960-
2016), Ovid Full-text (1980-2016), PsychINFO 
(1940-2016), PubMed, and EMBASE (1960-
2016). A manual search was also made on 
Google Scholar, the university libraries, and 
references lists of all retrieved literature to 
identify any missing papers from the electronic 
database searches. In addition, we contacted key 
authors in mindfulness research to enquire about 
any potential grey literature.
The search strategy to identify relevant papers 
involved a MESH (or INDEXTERM) term 
‘schizophrenia’ and keywords ‘psychot*’, 
‘psychos*’, ‘schizophreni*’, ‘serious mental 
disorder’, and ‘severe mental illness’ (and its 
combinations) for illness condition. In addition, 
intervention search terms were also included: 
‘mindfulness’, ‘mindful*’, ‘meditation’, 
‘MCBT’, and ‘MBSR’. Again, we had used the 
above search terms to search all the trials registers 
and databases. A sample search strategy was 
provided in Table 1.
  Eligibility criteria
Types of studies
The review considered any randomized-
controlled trials (RCTs) or experimental studies 
(published between January 2000-April 2016) 
that evaluated the effectiveness MBI for people 
with schizophrenia. These studies tested the 
effectiveness of MBI as an adjunct therapy with 
treatment-as-usual (TAU), compared with TAU 
alone or an active control, and over different 
follow-up periods. Studies that used quasi-
experimental or single-group, pre-test and post-
test design, cross-sectional design, qualitative 
methods, or case report was excluded.
Types of participants
Participants included those patients aged 18 years 
and older, with more than 50% of participants 
with a formal clinical diagnosis of one of the 
schizophrenia spectrum disorders, according 
to the criteria of Diagnostic and Statistical 
Manual, DSM-IV-TR (and the latest DSM-V), 
or ICD-10 classification of mental disorders. 
Schizophrenia-spectrum disorders mainly 
included schizophrenia, schizoaffective disorder, 
delusional disorder, schizotypal personality 
disorder, schizophreniform disorder, and brief 
psychotic disorder.
Types of intervention
Interventions of interest were the interventions 
adopting mindfulness training as the primary 
component to examine their treatment effects to 
patients with schizophrenia spectrum disorders. 
These interventions included but not be limited 
to face-to-face, individual or group, and 
telephone and/or internet modes of MBI.
The review excluded those trials that: (a) did 
not aim to examine treatment effects; (b) 
examined mindfulness as an adjunct but not 
the main component of another psychological 
treatment such as yoga-based, Acceptance 
and Commitment therapy-based, and other 
related psychological interventions. This review 
examined the effectiveness of the MBI and 
thus those sstudies had used mindfulness as 
an adjunct component of another treatment 
increased difficulties in dissociating the effect of 
mindfulness from other components and thus 
unable to draw meaningful conclusions on this 
particular emerging field of applied research [5].
Types of outcome measures 
Primary outcomes in this review were patients’ 
emotional regulation, global functioning, 
indicators for illness relapse/recurrence such as 
hospitalizations, and suicide and all causes of 
mortality. Secondary outcomes included overall 
symptomatology, level of mindfulness, quality 
of life, indicators for symptoms control such as 
Table 1: Results of literature search with keywords.
Steps Search term Number of articles retrieved 
1 mindfulness.ab. or mindfulness.ti. or mindfulness.ct. 1760
2 mindful*.ab. or mindful*.ti. or mindful*.ct. 2502
3 MBCT.ab. or MBCT.ti. or MBCT.ct. 102
4 MBSR.ab. or MBSR.ti. or MBSR.ct. 179
5 meditation.ab. or meditation.ti. or meditation.ct. 1304
6 or/1-5 3454
7 schizophreni$.ab. or schizophreni$.ti. or schizophreni$.ct. 35097
8 "mental disorder".ab. or "mental disorder".ti. or "mental disorder".ct. 2129
9 "mental illness".ab. or "mental illness".ti. or "mental illness".ct. 8356
10 ((serious or severe) adj3 mental).ab. or ((serious or severe) adj3 mental).ti. or ((serious or severe) adj3 mental).ct. 4400
11 "psychot*".ab. or "psychot*".ti. or "psychot*".ct. 30446
12 "psychos*".ab. or "psychos*".ti. or "psychos*".ct. 51343
13 or/7-12 113764
14 6 and 13 370
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compliance with medication and coping ability. 
The review also included other possible outcomes 
such as behavioral changes and economic benefits 
induced by the intervention.
  Study selection
The database search identified all potentially 
relevant studies based on the information 
contained in the title, abstract and descriptor/
MeSH headings. The studies were assessed 
against the inclusion and exclusion criteria by 
two independent reviewers (the first author and 
one research assistant) to ensure the studies could 
be classified correctly. Disagreements between 
reviewers on the articles with unlcear eligibilties 
were resolved by discussion and consensus made. 
The reviewer developed an electronic data 
extraction sheet, pilot-tested it on randomly-
selected studies to be reviewed, and refined it 
accordingly. Full text articles were then obtained 
and read in detail independently by the two 
reviewers. Data collection was conducted in May 
2016 and updated again in July of 2016. Only 
the latest reports were included when duplication 
occurred. 
Data extraction
Study data were extracted independently by 
the first and second authors and compared in 
order minimize errors in data extraction or 
their subsequent use for analysis. Information 
were extracted from the trial based on the 
characteristics of: (a) the trial (including the 
year of publication, design, randomization, 
concealment of allocation, blinding, number 
of participants, types of outcome measures, 
and follow-up periods in weeks); (b) the 
intervention(s) used (including treatment 
protocol, target population, treatment settings, 
length of treatment, attendance in number of 
sessions, and length of home practice in hours); 
(c) the comparison groups (including the 
number of participants, types of control, types 
of treatment, and length of treatment); and (d) 
the participants (including mean age, gender, 
diagnosis, duration of disease, education level, 
and work backgrounds).
Risk of bias
An external expert reviewer in systematic review 
independently assessed the risk of bias using the 
Cochrane Collaborations’ risk of bias assessment 
tool (Table 8.5a in the Cochrane Handbook for 
Systematic Reviews of Interventions) [14], which 
assessed the random sequence generation, 
allocation concealment, patient and personnel 
blinding, assessor blinding, incomplete outcome 
data, and selective outcome reporting. The use 
of this external reviewer could avoid potential 
conflicts of interest as the authors were closely 
involved in research on this topic. The relevant 
information was extracted from each study 
and finally rated as ‘high risk’, ‘low risk’ or 
‘unclear risk’, according to the criteria from 
the Cochrane assessment tool. Disagreements 
were resolved by consensus. The review used 
RevMan 5.1 (Review Manager 5.1) to compute 
graphic representations of potential bias. The 
reviewer considered each item in the risk of bias 
assessment independently without an attempt 
to collate and assign an overall score. The item 
ad final scores and reasons for these ratings were 
discussed among the research team in details so as 
to reach an objective agreement of the quality of 
each study reviewed. Indeed, the bias assessment 
results were not used to determine the inclusion 
criteria of these reviewed studies.
Strategy for data synthesis
Due to very much heterogeneity of the 
outcome measures (i.e., a few heterogeneity 
indexes: Tau-square= .49- .82, Chi-square= 
2.3-4.5, p= .15 - .30, I2= 15-30%) and thus 
the study findings, the review had to do the 
summary of the pooled results narratively with 
descriptive statistics, and textual descriptions 
and tables. Detail summaries presented for 
each of the studies reviewed included the main 
characteristics of the study reviewed such as 
total number of studies included, methods used 
and sample sizes, the findings regarding their 
effectiveness (in terms of the main outcomes) 
and feasibility, the quality of evidence, and 
their limitations and recommendations. To 
measure the magnitude of treatment effects, 
this review reported the estimated effect sizes 
(ES) for the continuous outcomes of all studies 
included and which were calculated with the 
formulas described by Lipsey and David [15], 
by dividing the difference of mean scores of 
one study outcome between two groups with 
the pooled standard deviation. For studies 
contained 3 or more study groups, the ES were 
calculated with F values, as again suggested 
by Lipsey and David 15. Using Cohen’s 
recommendations, effect sizes of interventions 
on psychosocial outcomes were leveled 
as: trivial (Cohen’s d ≤ .20), small (>.20), 
moderate (> .50), large (>.80), and very large 
(>1.30) [16].
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Results
  Study selection 
A total of 1,438 articles were retrieved from the 
electronic databases and manual search up to 
31 July 2016. After removing those duplicates, 
1,275 studies remained and were screened. About 
1,250 records were removed after screening the 
relevance of article titles and abstracts to the topic 
of the review. The full texts of the remaining 21 
studies were reviewed and finally 15 studies were 
excluded after full review, leaving behind only 
six studies [17-22] to be included for this review. 
Details of the searching process are shown in 
Figure 1.
  Study characteristics
Design of the included studies
In the six randomized controlled studies, two 
were pre- and post-test design [20,21] and the 
other studies (n= 4) [17-19,22] used repeated-
measures design with varied follow-up periods 
from 6 months [17] to 2 years [22].
Participants
Most of the participants were male (mean 
61%, median 59.3%, range 49.5%-97.1%) and 
middle-aged (mean 36.4, range 25.6-51.7). Two 
studies had conducted in people with recent-
onset psychosis (i.e., duration of illness < 5 years) 
[18,19]. One multicenter controlled trial targeted 
patients with distressing residual psychotic 
symptoms [17]. Most patients were diagnosed 
with schizophrenia (58.8%-38.2%); other 
patients were mainly diagnosed of schizoaffective 
disorders (9.5% - 66.6%), depressive disorder 
with psychotic feature (20.4% - 41.1%) and 
delusional disorder (4.7%). Four studies 
recruited patients with schizophrenia spectrum 
disorders according to DSM-IV but without 
reporting on the patient diagnoses [19-22]. The 
duration of the illness ranged from 2.6 (SD= 1.8) 
to 14.0 (SD=7.0) years. Only one study reported 
the lifetime hospitalization in the demographic 
characteristics, with an average of 4.4 years [22]. 
All studies reported the participants’ education 
levels, mainly high school education (55.3%) or 
average years of schooling 9.3 (SD= 2.8). Two 
studies reported patients’ working status, mainly 
unemployed (86.5%) [17,20]. 
Interventions
The six reviewed studies are summarized in 
Table 2. The studies were conducted in the U.S., 
U.K., Spain, and Hong Kong and three of them 
were multicenter trials [17-19]. Four studies 
focused on patients in community mental health 
settings, while 2 studies conducted in outpatient 
clinics [18-19]. All studies provided group-based 
mindfulness-based intervention; in which, two 
adopt solely mindfulness without combining 
to any other intervention [18,20]. Davis et al. 
[22] developed the Mindfulness Intervention for 
Rehabilitation and Recovery in Schizophrenia, 
which was integrated mindfulness into work 
counseling [17]. Chien and Lee [18] and Chien 
and Thompson [19] combined mindfulness 
training into a well-established psychoeducation 
programme. Chadwick et al. [17] integrated a 
person-based cognitive therapy into the MBI.
The MBI in these reviewed studies engaged 
patients in mindfulness training, home and 
within-session practices and reflective discussions, 
supplemented with CD or audiotapes for self-
practices. The structure of the interventions 
varied much in terms of length of each session 
and guidance of mindful exercises. Three studies 
introduced only one technique of mindfulness 
[18,19,22], while the other three studies 
instructed different mindfulness exercises; and 
however, homework and self-practices were not 
compulsory in most of the studies. Regular self-
practice was a key component of the program 
possibly to enhance treatment effects; whereas, 
more practice was associated with symptoms 
improvement [23,24]. Besides, the frequency 
and duration of the interventions varied from 
twice a week to biweekly, and 60 to 120 minutes. 
Nevertheless, the total number of sessions was 
mainly 12 sessions (i.e., standardized for MBI 
programs), except Davis et al.’s 32-session [22] 
and Langer et al.’s [20] 8-session programs. 
Indeed, the variations between the six MBI 
programs used in the reviewed studies may limit 
the potential generalization and replications of 
the intervention in future research and practice. 
Regarding the control group used, one study used 
waiting-list controls [20] and two only adopted 
treatment-as-usual (TAU) controls [17-18]; 
whereas, the remaining three studies adopted 
active control groups, including Intensive 
Support for work-related issues [22], integrated 
rehabilitation treatment [20] and conventional 
psycho-education program [19].
Risk of bias across studies 
Figures 2 and 3 indicated the item-based risk 
of biases and the bias assessment of the included 
individual studies. 
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Table 2: Summary of studies of MBI for people with schizophrenia.
Study Type of study Country
Type of 
participants 
Intervention
Control group Measures Main findings Attrition
Treatment protocol
Self-practice 
arrangement
Langer et 
al. (2012) 
[20]
Control trial, 
pre post 
design 
Spain 
SZ spectrum 
(N=18)
Group intervention 
(n=11)
8 weekly 60-min session 
(8 session). 8 pt/gp. 
Contents:
(a) Mindfulness practice: 
body scan, mindfulness 
breathing, and sitting 
meditation
(b) To use poetry and 
metaphors to help 
illustration
(c) To provide handouts 
of summarizing at the 
end of each session 
(a) Encourage 
home practice
(b) To provide 
CD on body 
scan and sitting 
meditation 
(c) To provide 
homework 
forms to 
complete
 
 
Waiting list (n=12)
CGI-SCH
AAQ II
SMQ
 
 
MBI shows 
beneficial result to 
improve patient 
in the ability to 
respond mindfully 
to stressful 
thoughts and 
images 
27.80%
López-
Navarroet 
al. (2015) 
[21]
Control trial, 
pre post 
design 
Spain 
SZ  + BAD 
(N=44)
Integrated rehabilitation 
treatment + MBI Group 
intervention (n=22)
26 weekly 60-min session 
(26 sessions). 10-12 
patient/group. Contents:
(a) Body awareness 
exercise and guided 
meditation
(b) Acceptance of bodily 
sensation, sensation of 
breathing and thoughts, 
images and voices  
(c) Let go of worry and 
engagement with the 
thoughts, voices or 
psychotic symptoms and 
(d) Reflective discussion 
on mindfulness practice
(a) Encourage 
home practice
(b) To provide 
an audio tape 
of mindfulness 
for home 
practice with 
the guidance 
instructions 
Integrated 
rehabilitation 
treatment (n=22)
26 weekly 60-
min session (26 
sessions); 10-12 
patient/group
Contents:
(a) CBT for 
symptoms 
management and 
social skills training
(b) 
Psychoeducation 
about SMI 
management, 
relapse prevention 
and conflict 
management
 
 
WHOQOL-BREF
PANSS
MAAS
 
 
 
MBI + Integrated 
Rehabilitation 
Treatment 
improved health-
related quality 
of life 
in the area of 
psychological, 
physical and 
environmental 
dimensions in 
people with 
severe mental 
illness. 
9%
Davis et 
al. (2015) 
[22]
Control trial, 
repeated 
measures
U.S. 
SZ spectrum 
(N=34)
Group intervention 
(n=18)
Twice weekly 75-min 
session for 16 weeks 
(32 sessions), 8 pt/gp. 
Contents:
(a) Mindfulness skill and 
practice; 
(b) Experiential exercise 
and discussion of 
meditation, stress 
response and the effect 
of meditation in study 
and work 
(c) To provide handout 
for a review of main 
points from classes and 
tips for home practice 
(a) Assigned 
daily home 
practice. 
Participants 
had to submit 
the track record 
each week
(b) To provide 
CD player 
of a guided 
meditation 
recording for 
20-30 min, 
brief informal 
practice of 
mindfulness 
during daily 
activities  
 
 
Intensive support 
(n=16)
(a) A weekly 90-min 
group sessions 
for work related 
discussion and 
support.
(b) Allow individual 
appointment upon 
request
 
 
 
Weeks/hours 
  of work, 
WBI
CAS
MFS
CSQ
PANSS
Participants of 
MIRRORS have 
greater number 
of working hours 
and better work 
performance 
9%
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Chien and 
Lee (2013) 
[18]
multicenter 
RCT , repeated 
measures 
design
HK
SZ with 
duration of 
disease <5 
years (N=96)
Group intervention 
(n=48)
Biweekly 120-min 
session for 24 weeks (12 
sessions). Contents:
(a) Orientation 
and engagement, 
empowerment and 
awareness of experience 
and bodily sensation 
(b) Educational and 
survival workshop, 
coping skill for 
symptoms
(c) behavioral rehearsals 
of relapse prevention, 
community support 
resources 
(d) Cultural specific: 
interdependence, 
reconstruction of self-
image 'save face'
Required a 
regular daily 
practice 
TAU (n=48) 
BPRS
SLOF
SSQ-6
ITAQ
Number and   
length of re-
hospitalization
 
Mindfulness 
psychoeducation 
program 
improves patients' 
illness insight, 
symptom severity, 
functioning, and 
number and 
length of re-
hospitalization 
at 18 month 
follow-up
6%
Chien and 
Thompson 
(2014) 
[19]
Multicenter 
RCT, repeated 
measures 
design
HK
SZ with 
duration of 
disease <5 
years (N=107)
Group intervention 
(n=36)
Biweekly 120-min 
session for 24 weeks (12 
sessions). Contents:
(a) Orientation 
and engagement, 
empowerment and 
awareness of experience 
and bodily sensation 
(b) Educational and 
survival workshop, 
coping skill for 
symptoms
(c) behavioral rehearsals 
of relapse prevention, 
community support 
resources 
(d) Cultural specific: 
interdependence, 
reconstruction of self-
image 'save face'
Required a 
regular daily 
practice 
A. Conventional 
psychoeducation 
program (n=36). 
Contents: 
(a) Engagement & 
empowerment
(b) Education 
and survival skill 
workshop, problem 
solving training 
for prevention of 
relapse 
(c) Problem 
solving training 
for prevention of 
relapse 
B. TAU (n=35)
 
BPRS
SLOF
SSQ-6
ITAQ
Number and 
 length of   re-
hospitalization
 
MBIs improves 
in psychiatric 
symptoms, 
psychosocial 
functioning, 
insight, time 
and duration 
of readmission, 
compared to 
conventional 
psychoeducation 
and TAU. long 
term benefits:  
over 24 months 
11.2%
Chadwick 
et al. 
(2016) 
[17]
Multicenter, 
single blind, 
pragmatic 
randomized 
control trial  
U.K.
SZ with 
distressing AH 
(N=108)
Group person-based 
cognitive therapy (n=54)
12 weekly 90-min 
sessions (12 sessions). 
Contents:
(a) Guidance on 
reference to psychotic 
experience, combined 
with focused attention 
on body and breath with 
open awareness
(b) Using ABC cognitive 
model to drew out AH 
experiences 
(c) Identify and 
decentering from 
negative schemata, 
and building positive 
schematic belief 
(a) Encourage 
daily home 
practice
(b) Provide a 10 
min recording 
(c) Weekly 
homework 
related to voices 
of self
 
 
TAU (n=54) 
 
 
 
 
CORE
PSYRATS: AH
HADS
CHOICE
 
PBCT significant 
reduce the level 
of distress of AH, 
with the effect 
maintained at 6 
month follow-up
24%
Pt = patient;  gp = group SZ = schizophrenia;  AH = auditory hallucination;  CGI-SCH = The Clinical Global Impressions Scale;  AAQ II = Acceptance and action scale;  SMQ 
= Southampton mindfulness questionnaire;  WBI = Work behavior inventory;  CAS = Change assessment scale;   MFS = Mindfulness fidelity scale;  CSQ = The Clinical 
satisfaction questionnaire;  PANSS = Positive and negative syndrome scale;  CBT = cognitive behavioral therapy;  SMI = severe mental illness;  WHOQOL-BREF = World health 
organization quality of life-BREF;  MAAS = Mindfulness attention awareness scale;  BPRS = Brief psychiatric rating scale;  SLOF = Special level of functioning scale;  SSQ-6 = 
Social support questionnaire;  ITAQ = Insight and treatment attitudes questionnaire;  TAU = Treatment as usual;  CORE = Clinical outcomes in routine evaluation;  PSYRATS: 
AH = The Psychotic Symptom Rating Scales: Auditory hallucination scale;  HADS = Hospital anxiety and depression scale;  CHOICE = Choice of outcome in CBT for psychoses
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  Study Group Allocation 
Sequence generation and allocation 
concealment
The study of Davis et al. [22] randomized the 
participants in blocks of four, creating a relatively 
high risk of sequence generation. Three studies 
were ranked as ‘unclear risk’ because they did not 
describe the randomized sequence generation 
[17,18,20]. Two studies were in low risk of 
sequence generation by using computerized 
randomization and opaque envelope [19,21]. 
For allocation concealment, four studies did 
not describe how the allocation was performed 
[17,18,20,22]; the allocation concealments were 
therefore rated as ‘unclear’. The other two studies 
were in low risk of allocation concealment 
due to its clear description of the allocation 
concealment.
Blinding 
Most studies were at high risk of performance 
bias (blinding of participants and personnel) 
due to the nature of the intervention used (i.e., 
the mindfulness intervention). The authors 
themselves led the MBI in Davis et al.’s 
[22] study; and Chien and Thompson [19] 
highlighted the research team’s training on the 
psychiatric nurses, which violated the blinding 
of personnel in the study settings. Therefore, the 
blinding of personnel in these two studies were 
rated ‘high risk’, while the other four studies did 
not describe the blinding of personnel and thus 
were rated ‘unclear’. 
All studies adopted self-reported measures, in 
which four studies assigned blinded assessors to 
measure the study outcomes. The detection biases 
(blinding of outcome assessment) were rated as 
‘unclear’. Davis et al. [22] assigned a graduate 
psychologist experienced in mindfulness training 
to assess the study outcomes and thus its 
detection bias could be rated as ‘high risk’. 
In addition, five studies were in low risk of 
attrition bias with a loss to follow-up of 20% or 
less. Two studies were rated ‘high risk’ in this 
bias because of its high loss to follow-up (>20%) 
[17,20]. 
1432 retrieved from searching six 
databases
1275 abstracts 
screened 
21 full text articles 
assessed  
6 full text articles 
included 
1275 records after  
duplicates removed  
1254 records excluded by 
checking title and abstract
15 records excluded after full review 
1 X qualitative study
1X ACT based 
8 X < 50% or unknown types of disorders
1 X intervention widely involved other appraoch
6 X non-control studies
6 retrieved from 
hand searching
163 duplicates
Figure 1: Results of literature search in PRISMA flow diagram.
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Figure 2: Risk of bias graph.
Figure 3: Summary table of risk of bias for individual studies reviewed.
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For reporting bias, most of the studies clearly 
reported all the results according to the protocol 
and thus they were rated ‘low risk’ in the selective 
reporting bias [17-21]. Only Davis et al.’s [22] 
study failed to describe all of the main outcomes 
listed in the protocol, thus being rated ‘high risk’ 
on selective reporting bias. 
  Results of individual studies
Table 2 shows the results of the six studies 
in terms of their study design, number 
of participants, randomization, types of 
intervention and control groups, and outcome 
measures at both post-treatment and the last 
follow-up. Table 3 shows the effect sizes of MBI 
on each of the main study outcomes. Because the 
study design, intervention and reported outcome 
measures varied markedly, the article focused on 
describing the studies including the results and 
the limitations on descriptive synthesis.
Only one RCT investigated the effect of MBI 
on emotional regulation. Chadwick et al. [17] 
measured patients’ distress and anxiety with 
Hospital Anxiety and Depression (HADS), and 
the clinicians’ rating on Psychotic Symptom 
Rating Scale - distress intensity (PSYRATS). 
There were significant between-group differences 
in HADS depression and PSYRATS, with small 
to moderate effect size (Cohen’s d= -0.38 for 
HADS depression and -.50 for PSYRATS or 
distress intensity). A significant between-group 
difference was maintained on HADS depression 
with small effect size (d= - .36) at 6-month 
post-intervention. However, the studied did 
not demonstrate between-group difference of 
MBI on CORE-OM and HAD anxiety at post-
treatment or 6-month follow-up, indicating 
there were no improvements on patients’ anxiety 
and general psychological symptoms after 
completion of the intervention. 
The study from Chien and Thompson [19] 
demonstrated MBI significantly improved 
schizophrenia patients’ psychosocial functioning 
by using Specific Level of Functioning Scale 
(SLOF), with moderate effect size (d= .54). 
The significant between-group difference could 
be sustained to both 12-month and 24-month 
post-intervention (d= .55 at 12-month and 
.57 at 24-month follow-up). Another study 
from Chien and Lee [18] also demonstrated a 
significant between-group difference on SLOF 
score at 18-month follow-up with moderate 
effect size (d= .57). 
Two studies by Chien and his research team 
measured the effects of MBI on preventing relapse 
from the illness [18,19]. These studies measured 
the average number of re-hospitalizations and 
duration of re-hospitalizations to indicate 
the participants’ relapse rate. Their study 
in 2013 demonstrated significant between-
group differences on participants’ number and 
duration of re-hospitalizations over 18-month 
follow-up, with moderate and large effect size, 
respectively (for average number of admissions, 
d= - .52 at 18-month follow-up; for duration of 
re-admission, d= - .87 and -1.27 at immediately 
and 18-month post-intervention, respectively) 
[18]. Another Chien’s study also showed 
significant between-group differences on the 
duration of re-hospitalizations at immediately, 
12- and 24-month post-intervention with 
mainly moderate effect sizes (d= .38 to .56) [19].
For the secondary outcomes, all studies measured 
the symptoms severity by using different 
measurement tools. Both studies of Chien et 
al. [18,19] demonstrated significant between-
group differences on the Brief Psychiatric 
Rating Scale (BPRS) at post-intervention, with 
small to moderate effect size (d= - .36 and .57, 
respectively). Their study in 2013 showed the 
effect was maintained at 18-month follow-up 
(moderate effect size, d= -0.674); [18] whereas, 
the study in 2014 showed the sustainable effect 
of MBI at 12-month and 24-month follow-up 
with moderate effect sizes (d= .52 at 12-month 
and .55 at 24-month follow-up) [19].
Langer et al. [20] evaluated their patients’ 
symptoms with the use of Clinical Global 
Impression – Schizophrenia Scale (CGI-SCH). 
The results demonstrated the moderate effect size 
in CGI-SCH (d= - .66), despite the change not 
reaching significant between-group difference. 
This might be due to the study had a very small 
sample size (n=18), thus having inadequate 
power. Indeed, Lopez-Navarro et al. [21] and 
Chadwick et al. [17] measured symptom severity 
with the use of Positive and Negative Syndrome 
Scale (PANSS) and Psychiatric Symptom Rating 
Scale (PSYRATS), respectively. Both studies 
failed to show a significant between-group 
difference on symptom improvement after MBI. 
However, Langer, et al. [20] showed the MBI 
significantly improved patients’ mindfulness 
response as showed by the Southampton 
Mindfulness Questionnaire (SMQ), exhibiting 
a large effect size (d= 1.20). On the other 
hand, Lopez-Navarro, et al. [21] did not show 
statistically significant between-group difference 
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in Mindfulness Attention Awareness Scale 
(MAAS), with a small effect size only (d= .21).
In addition, only one RCT investigated the 
effect of MBI on participants’ quality of life. 
Lopez-Navarro, et al. [21] investigated the 
effect of MBI on patients’ quality of life using 
the World Health Organization Quality of Life-
BREF (WHOQOL-BREF). The results showed 
the MBI program significantly improved the 
patients’ psychological health-related quality of 
life, with a moderate effect size (d=.63). But the 
MBI did not show significant improvements in 
their life satisfaction in terms of physical, social 
and environment aspects, when compared to the 
control group. 
Furthermore, Chadwick et al. [17] identified 
the patients’ overall level of recovery using the 
Choice of Outcome in CBT for Psychoses 
(CHOICE). There was significant between-
group effect on CHOICE-satisfaction after 
the intervention (d= .38), representing one’s 
satisfaction on enhancing their self-confidence 
and coping with stress [25]. However, the effect 
could not sustain to the 6-month follow-up. 
In addition, there is no significant between-
group difference on CHOICE-severity, which 
measured the symptom disruption and control 
(d= .35 at post-intervention and .31 at 6-month 
follow-up). Langer, et al. [20] measured the effect 
of MBI on patients’ experiential avoidance (i.e., 
the willingness to experience unwanted private 
events) using the Acceptance and Action Scale 
(AAQ II). The MBI did not show significant 
improvement on AAQ II at post-intervention. 
Chien et al. [18,19] measured the effects 
of mindfulness-based psyechoeducation 
intervention on patients’ awareness of and 
insight into illness and treatment with Insight 
and Treatment Attitudes Questionnaire 
(ITAQ). Both studies showed significant 
between-group differences in the ITAQ scores 
at post-intervention, with moderate to large 
effect size (d=1.26 and 0.60, respectively). Study 
in 2013 showed the effect was maintained at 
18-month follow-up, with very large effect size 
(d= 2.00) [18]. Chien et al.’s study in 2014 
also demonstrated significant between-group 
differences at 12- and 24-month follow-up, with 
moderate effect sizes (d= .68 and .72 in 12- and 
24-month follow-up, respectively) [19]. These 
two studies also examined the effect on patients’ 
satisfaction with the social support available in 
one’s immediate social environment by using 
Social Support Questionnaire (SSQ) but failed 
to demonstrate its significant improvement on 
SSQ score after MBI.
For other study outcomes, Davis et al. [22] 
investigated the effect of a MBI rehabilitation 
program on work performance. The work 
performance was measured by the Work 
Behavior Inventory (WBI). There was a 
significant between-group difference in WBI 
after post-intervention, with a large effect 
size (d= 1.06) and a substantive large effect at 
6-month post intervention (d= .89). There 
were also significant between-group differences 
on the WBI subscales - WBI work quality and 
QBI personal presentation, with large effect sizes 
(both d= .91). 
Discussion 
Recently, there has been emerging attention and 
increasing research on the effects of mindfulness-
based intervention (MBI) in schizophrenia 
spectrum disorders. This review examined the 
current research evidence on the effectiveness of 
MBI for people with schizophrenia on a variety 
of patient outcomes over different periods of 
follow-up. The findings of this review show that 
although only six controlled trials have been 
identified, there are encouraging effects of MBI 
for these patients on a few important clinical 
outcomes, such as psychosocial functioning, 
work behaviors, psychiatric symptoms, 
depression, psychological distress, and relapse 
rate in short-term. In addition, there are also 
a few postive effects found over a longer-term 
(12-24 months) follow-up on these patients’ 
functioning, psychotic symptoms, insight into 
the illness, and relapse prevention [18,19]. 
However, there have not yet sufficient and 
conclusive evidence to indicate these promising 
effects due to limited number (n=6) and 
fairly satisfactory quality of controlled trials 
identified in the past decades. In addition, few 
studies adopted rigorous or high quality study 
design and half of the reivewed studies mainly 
had small sample size (i.e., 18-44 sample) and 
violations on selection, performance, detection, 
and reporting biases, which have threatened the 
internal and external validity of the findings. 
Half of the reviewed studies did not mention 
the sample size calculation, thus failing to ensure 
sufficient statistical power. In addition, most 
of the significant improvements on the patient 
outcomes were found in two to three studies 
identified [17-19], which had relatively larger 
sample size and higher quality of study design. A 
Neuropsychiatry (London)   (2016) 6(5)219
Review Wai Tong Chien
few significant improved patient outcomes, for 
instance, the global functioning and insight into 
the illness and its treatments, were measured in 
the two studies of culturally-adopted MBI by the 
same research team in Hong Kong. These two 
studies might involve similar patient groups, 
study settings and treatment protocols, raising 
uncertainty about the replication of the findings 
and implications. 
This review observed a few similar limitations 
to another systematic review on the effects of 
MBI by Strauss et al. [26]. The review reported 
that there was a lack of consensus on the 
therapeutic ingredients or components of the 
MBI used, its specific effects to the target patient 
groups, and the primary and other main study 
outcomes to be focused in the controlled trials. 
As the study outcomes have varied much in the 
reviewed studies, it would be hard to answer 
on the mechanism of therapeutic actions, or 
how the MBI induced positive changes among 
participants. Surprisingly, there are only 
few controlled trials investigating about the 
effect of MBI on emotional regulation, which 
may be the key functions of this approach 
to psychological therapy [5]. The emotional 
regulation of people with schizophrenia can 
contribute to an improvement of one’s global 
functioning and psychological distress due to 
psychotic symptoms; whereas, mood instability 
is a prominent feature of schizophrenia, as well 
as patients’ relapse from the illness [27,28]. 
While MBI aims to promote a sense of calmness 
and confidence to accept negative and distressed 
thoughts and feelings, there is a need for 
better understanding the therapeutic effect of 
MBI on emotional regulation in people with 
schziophrenia, particualarly those with persistent 
halluciation and/or delusion. 
In addition, there were only two studies 
investigated the illness relapse or recurrence, 
assessing merely on patients’ duration and length 
of re-hospitalizations [18,19]. Relapse prevention 
is crucial in schziophrenia because each relapse 
increases a psychotic patient’s residual symptoms 
and cotninuous, gradual functional impairments 
and disabilities, leading to disruption of one’s 
life and burdens on family and carers [1,29]. 
Therefore, there are very high re-admission rates 
of people with schizophrenia spectrum disorders 
due to symptom recurrrence and relapse, with a 
prevalence of 30-50% in one year and 70% in 10 
years [30,31]. This high risk of re-hospitalization 
or relapse in schziophrenia has raised much 
concern globally because this can create a huge 
demand for mental health care services and the 
related costs, as well as the overall disease burden 
in societies [2,30]. While the current evidence 
has showed that MBI may benefit in reduction 
of duration (or number) of re-hospitalizations, 
further investigation is recommended to 
capture this cost-benefit and other longer-
term benefits such as utlization of health care 
services, mortality and co-morbidities, as well 
as patients’ integration into the communtiy and 
producitivity in work and family care. This can 
then prove the possibility of changing the overall 
trajectory of schizophrenia.
The structure of MBI programs highly varied 
in the six reviewed studies. A few trials only 
instructed one main mindfulness technique, 
while the other studies taught a few mindful 
techniques such as body scan and sensation, 
mindful breathing, walking and siting 
meditation, and stress responses. The frequency 
and duration of the interventions also varied 
from 4 to 14 sessions and one to three hours, 
respectively. This diversity of the MBI programs 
used may not help us find out the optimal and 
acceptable structure, content and frequency/
duration of MBI for people with schizophrenia, 
resulting in higher attendance or completion rate 
(or lower attrition rate; whereas, 6-18% in the 
reviewed studies) and better patient outcomes. 
Indeed, these variations would limit the potential 
for generalization and replication of this MBI 
program in research and practice. 
Furthermore, most of the studies did not 
request for very formal (or regular) home 
practices. Crane et al. [32] discovered the strong 
association between the level/length of formal 
home mindful practices and the depressive 
patients’ desirable outcomes. It is evidenced that 
people who have engaged in more formal/regular 
home meditation practices would have a more 
significant lower risk of relapse from depression 
over 12 months [32], and thus, this may also be 
applied to schizophrenia and other severe mental 
illnesses. Unfortunately, there was only one of the 
six reviewed studies recorded the patients’ duration 
of home practices [22] and thus we cannot decide 
the optimal dose/amount of mindfulness practices 
to bring out most positive patient outcomes in the 
trials and hence provide guidance for clinicians to 
work out the most appropriate pattern of home 
exercises for the users.
A few controlled trials in this review integrated 
the MBI into another conventional intervention 
such as psycho-education, work counseling and 
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cognitive therapy. These trials have demonstrated 
very desirable patient outcomes, when compared 
with the control groups. For instance, Chien 
et al.’s [18,19] studies demonstrated that the 
integrated mindfulness and psycho-education 
program significantly improved a variety of patient 
outcomes, including psychotic symptoms, insight 
into illness and treatment, psychosocial functioning, 
and average duration of re-admissions. Chadwick, 
et al. [17] also demonstrated that Person-based 
Cognitive Therapy incorporated with mindfulness 
training to be the main component sustainably 
reduced the patients’ psychological distress 
regarding hallucinations over 6 months follow-
up. Mindfulness alone solely engage participants in 
recognizing and accepting the internal events without 
explicitly focusing and reinforcing on skills/technique 
of behavioral change and illness management. A 
combination of mindfulness to other psychological 
therapies entails the notion of ‘theoretical integration’, 
which integrates different principles of psychological 
therapies from two or more approaches in order 
to amplify or synergize the therapeutic purposes 
and objectives of MBI [33,34]. An integrated MBI 
program may provide more comprehensive and 
some unexpected therapeutic effects to people with 
schizophrenia. Further research may investigate the 
most optimal combination and synergetic effects 
of any integrated MBI, together with one or more 
conventional interventions, and which may target 
for specific goals or benefits to any subgroups of 
schizophrenia spectrum disorders.
Limitations of the study
Because of much varying study design, structure 
of intervention and patient outcomes used, 
we could not perform a meta-analysis in this 
review and thus the findings on the effects of 
MBI are less conclusive and valid. The review 
only included experimental studies published in 
peer-reviewed journals using English language 
and any unpublished research and relevant 
literature in other languages or other forms 
of publications were excluded. This could 
limit the generalizability and validity of the 
findings of this review. The results of risk of 
bias assessment showed much violations and 
various types of biases according to the valid 
Cochrane Collaboration’s assessment tool are 
found among the six reviewed studies, leading 
to possible under-powering the quality of the 
reported results and/or over- or under-estimate 
their treatment effects. For instance, the pooled 
samples are predominated with male (61.0%) 
and unemployed (86.5%) patients. These 
samples might not be representative to the patient 
populations, thus reducing the generalization of 
their reported results/effects of MBI participation. 
Nevertheless, the reviewed studies included 
different phases of schizophrenia, varying from 
early, recent-onset to chronic schizophrenia. This 
inclusion of heterogeneous subjects in terms of 
illness conditions/phases could have been useful 
to understand the wider applicability of MBI 
in different stages of schizophrenia. Lastly, this 
review included the randomized controlled trials 
but neither that with other study methods/designs 
nor those with mixed methods or qualitative 
exploratory approaches, and that would limit the 
comprehensive or in-depth understanding of the 
process, perceived benefits and different clinical 
outcomes of MBI in schizophrenia. The highly 
varied structure and content of the intervention 
used in the reviewed trials might also create threats 
to the internal or conclusive validity [35,36].
Implications for research and practice 
There is insufficient evidence on the significant 
positive effects of MBI for people with 
schizophrenia on important or long-term 
clinical outcomes. The mechanisms of the 
therapeutic actions of MBI in schizophrenia 
are uncertain or unexplored. This review 
has identified several knowledge gaps for 
future research. First, further research can be 
conducted to clearly identify the mechanism of 
actions and key therapeutic effects of MBI on 
crucial patient outcomes, including emotional 
regulation, various aspects of functioning, self-
empowerment, and efficacy and ability of illness 
management. Second, it is also important and 
useful to investigate the long-term benefits of 
MBI such as relapse prevention and quality 
of life, as well as cost-effectiveness in diverse 
groups of schizophrenia spectrum disorders. 
Third, high-quality randomized controlled 
trials with larger-sized sample should be used 
to increase the power of the study and validity 
of the findings. However, treatment protocols 
adopted in the current trials highly varied, thus 
limiting the consistency and replicability of MBI 
program delivered for research and practice. 
Identifying the therapeutic components of 
MBI may help in assuring the standardization 
of the treatment protocol. Finally, it is useful 
to examine the optimal/desirable effects of any 
integrated MBI with other approach (es) to 
psychosocial intervention(s). Further research 
may investigate the feasibility and effectiveness of 
an integrated use of such combined approaches 
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to psychological interventions so as to provide 
holistic and synergetic treatment effects to these 
psychotic patients with treatment-resistant or 
recurrent and chronic illness condition.
Conclusion 
There is an increasing recognition of the 
potential therapeutic effects of MBI for patients 
with schizophrenia. While a few recent pilot 
studies have demonstrated its flexibility and 
acceptance to people with schizophrenia 17, this 
review shows that MBI may have significant 
benefits to patients with recent-onset or chronic 
schizophrenia on inducing insight into the 
illness and symptom control, as well as a few 
aspects of functioning. However, there are only 
six controlled trials found to demonstrate such 
promising evidence, leaving rooms for further 
research with larger-sized sample and longer-
term follow-up. The review also reveals that there 
is a lack of standardized treatment protocol or 
common primary or main outcomes used in 
the reviewed studies, making firmly conclusions 
or recommendations on the intervention and 
its treatment effects more difficult. Therefore, 
further research should focus on adequate powered 
randomized controlled trials with diverse patient 
characteristics and long-term follow-up, as well as 
a standardized treatment protocol and a few similar 
patient outcomes to recent research.
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